Skip to main content

Advertisement

Erratum to: A commentary on the 2015 Canadian Clinical Practice Guidelines in glutamine supplementation to parenteral nutrition

Article metrics

The original article was published in Critical Care 2016 20:7

The author would like to issue an erratum for this article [1], and would like to declare the following competing interests which were inadvertently missed in the original publication.

Competing interests

I declare that I worked as an external freelance scientific consultant for Fresenius Kabi in Chile. My work has been limited to bibliographical analysis in the metabolic field non related with clinical practice. I have not endorsed products of Fresenius Kabi company, particularly Dipeptiven.

Reference

  1. 1.

    Leguina-Ruzzi A. A commentary on the 2015 Canadian Clinical Practice Guidelines in glutamine supplementation to parenteral nutrition. Critical Care. 2016;20:7.

Download references

Author information

Correspondence to Alberto Leguina-Ruzzi.

Additional information

The online version of the original article can be found under doi:10.1186/s13054-015-1175-3.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark